Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Overcoming challenges in flavivirus vaccine development: Exploring modern vaccine types for Dengue, Zika, and beyond

Researchers discuss the challenges impeding the development of vaccines against flaviviruses.

4 Apr 2023

Updated booster shots vital for keeping COVID-19 in check

Between natural infection and a global vaccination campaign, most people now have some immunity against the virus that causes COVID-19.

3 Apr 2023

Study identifies ultra-broad SARS-CoV-2 neutralizing antibodies that target various spike epitopes

Researchers screened the circulating B lymphocyte repertoires of coronavirus disease 2019 convalescents and vaccines using multiplexed antigen panels.

3 Apr 2023

Study indicates interspecies transmission of SARS-CoV-2 between humans and their pets occurs regularly

Researchers assessed severe acute respiratory syndrome coronavirus 2 seroprevalence among domestic pets.

3 Apr 2023

Probiotic E. coli secretes proteins of therapeutic value into its surroundings

Humans are colonized with thousands of bacterial strains. Researchers are now focused on genetically modifying such bacteria to enhance their intrinsic therapeutic properties.

31 Mar 2023

The breadth of immune responses following COVID-19 vaccination in hematology patients with diseases and treatments impacting B cell immunity

A study published in Cell Reports Medicine describes that COVID-19 vaccines induce strong T cell response in blood cancer patients, irrespective of antibody response and B cell numbers.

30 Mar 2023

Study predicts the country-specific impact of maternal vaccination against respiratory syncytial virus

Researchers developed a mathematical model to predict the potential impact of maternal vaccination on RSV-related childhood mortality.

30 Mar 2023

Lab-made antibodies may be able to cure people infected with yellow fever

New research from Oregon Health & Science University and collaborators indicates lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there is no treatment.

29 Mar 2023

Hematology patients generate robust immune responses against SARS-CoV-2 after vaccination

Researchers found that, despite being heavily immunocompromised, hematology patients generate strong cellular immune responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals.

29 Mar 2023

Targeting obesity: findings reveal a new molecular pathway involved in energy homeostasis regulation

Study outlines molecular mechanisms to aid the development of new therapies to manage obesity and associated health disorders.

29 Mar 2023

People with asthma or eczema more likely to develop osteoarthritis

Stanford Medicine scientists and their colleagues have found that having asthma or eczema increases the likelihood of developing osteoarthritis — signaling that there may be an allergic pathway that can be targeted with existing drugs.

28 Mar 2023

New combination therapy shows promising results in some patients with advanced head and neck cancer

A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.

28 Mar 2023

NPC1L1-EGFP mice enable researchers to fluorescently visualize, evaluate vesicular endocytosis

Excessive cholesterol absorption from intestinal lumen contributes to the pathogenesis of hypercholesterolemia, which is a well-established risk factor for atherosclerotic cardiovascular disease.

28 Mar 2023

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Researchers in the US examined the neutralization evasion and receptor affinity properties of SARS-CoV-2 Omicron BA.2.75 sub-variants.

28 Mar 2023

New study suggests broad neutralizing antibody could provide three years of COVID protection

In a recent article published in the journal Science Translational Medicine, researchers showed that a novel, lab-engineered monoclonal antibody (mAb), adintrevimab conferred up to 50% protection against symptomatic coronavirus disease 2019 (COVID-19). Furthermore, it demonstrated this exceptional efficacy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naïve individuals even at titers as low as 1:30.

27 Mar 2023

COVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancy

Researchers investigated the effects of the booster coronavirus disease 2019 (COVID-19) vaccine during pregnancy on COVID-19-related hospitalization rates among infants.

27 Mar 2023

Chronological and biological age may be important determinants of vaccine-preventable outcomes

A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 5, entitled, "Parsing chronological and biological age effects on vaccine responses."

27 Mar 2023

Researchers discuss strategic actions to stimulate research on fungal diseases in the context of the WHO fungal pathogens priority list

Researchers in the US and Brazil explored priority fungal pathogens recognized by the WHO.

27 Mar 2023

SARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine era

Researchers in the United States assessed the risk associated with SARS-CoV-2 reinfection.

27 Mar 2023

Researchers isolate an IgM exhibiting ultrapotent neutralization from a Zika virus-infected pregnant woman

A recent study published in the Cell Press Journal demonstrated that plasma immunoglobulins of isotype M elicited during pregnancy have an exceptional Zika virus-neutralizing potential.

27 Mar 2023

Antibody News and Research

Further Reading

Overcoming challenges in flavivirus vaccine development: Exploring modern vaccine types for Dengue, Zika, and beyond

Updated booster shots vital for keeping COVID-19 in check

Study identifies ultra-broad SARS-CoV-2 neutralizing antibodies that target various spike epitopes

Study indicates interspecies transmission of SARS-CoV-2 between humans and their pets occurs regularly

Probiotic E. coli secretes proteins of therapeutic value into its surroundings

The breadth of immune responses following COVID-19 vaccination in hematology patients with diseases and treatments impacting B cell immunity

Study predicts the country-specific impact of maternal vaccination against respiratory syncytial virus

Lab-made antibodies may be able to cure people infected with yellow fever

Hematology patients generate robust immune responses against SARS-CoV-2 after vaccination

Targeting obesity: findings reveal a new molecular pathway involved in energy homeostasis regulation

People with asthma or eczema more likely to develop osteoarthritis

New combination therapy shows promising results in some patients with advanced head and neck cancer

NPC1L1-EGFP mice enable researchers to fluorescently visualize, evaluate vesicular endocytosis

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

New study suggests broad neutralizing antibody could provide three years of COVID protection

COVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancy

Chronological and biological age may be important determinants of vaccine-preventable outcomes

Researchers discuss strategic actions to stimulate research on fungal diseases in the context of the WHO fungal pathogens priority list

SARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine era

Researchers isolate an IgM exhibiting ultrapotent neutralization from a Zika virus-infected pregnant woman

Immunology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo